# FDA 483 - Robert Donald Harvey - March 24, 2017

Source: https://www.globalkeysolutions.net/records/483/robert-donald-harvey/529c96fa-8e8c-4aee-8c28-1f7fecd9511a

> FDA 483 for Robert Donald Harvey on March 24, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Robert Donald Harvey
- Inspection Date: 2017-03-24
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: The FDA inspected Robert Donald Harvey, a clinical investigator in Atlanta, GA, and issued a Form 483. The inspection revealed that nonclinical laboratory studies were not conducted according to the established protocol, specifically regarding the timing of chemistry and hematology safety labs for multiple subjects. This indicates a significant deviation from study procedures.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/sereen-g-morgan-murray/1900ad73-5999-471e-8f74-63627bd1aa2a)

Company: https://www.globalkeysolutions.net/companies/robert-donald-harvey/10d1f388-42d6-4f3d-a876-af0d2a39e474

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7